Perrigo Co (MEX:PRGON) Moat Score: 5/10 (As of Jun. 24, 2026)


MEX:PRGON Perrigo Co PLC MEX:PRGON
44 GF Score
Price MXN557.52
GF Value MXN1,468.70
! 4 Warning Signs
View Full Analysis

What is Perrigo Co Moat Score?

Perrigo Co MEX:PRGON 44 Moat Score is 5 as of Jun. 24, 2026. GuruFocus rates MEX:PRGON with a GF Score™ of 44/100 and a GF Value™ of MXN1,468.70. The stock has 4 warning signs investors should review. Among 1,033 Drug Manufacturers companies, Perrigo Co ranks better than 94.68% on this metric.

Perrigo Co has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Perrigo Co has Narrow Moat: Perrigo Co PLC has a solid narrow moat with strong brand strength in the consumer healthcare sector. The company benefits from economies of scale and a robust distribution network. However, the competitive landscape and moderate pricing power prevent it from achieving a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Perrigo Co might have Narrow Moat - Solid narrow moat.

Perrigo Co  (MEX:PRGON) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Perrigo Co Moat Score Related Terms

MEX:PRGON vs AMLX, HROW, ANIP: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perrigo Co Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Moat Score distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Moat Score falls into.


MEX:PRGON
44GF Score
Perrigo Co PLC MEX:PRGON
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Perrigo Co (MEX:PRGON) has a Moat Score of 5 as of Jun. 24, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Perrigo Co ranks #55 out of 1033 companies in the Drug Manufacturers industry, placing it in the top 5.3%.
Is Perrigo Co's Moat Score too high?
Perrigo Co's current Moat Score is 5. Based on the distribution chart, Perrigo Co ranks #55 out of 1033 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Perrigo Co has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's Moat Score compare to AMLX and HROW?
According to the Drug Manufacturers industry distribution chart, Perrigo Co ranks #55 out of 1033 companies for Moat Score. This places Perrigo Co in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Perrigo Co's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Perrigo Co (MEX:PRGON) has a current Moat Score of 5. The stock's GF Value™ is MXN1,468.70, compared to a current price of MXN557.52 — trading 62% below its estimated fair value. The current Moat Score is 5. Perrigo Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Perrigo Co (MEX:PRGON), the current Moat Score is 5 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perrigo Co (MEX:PRGON) Overvalued in 2026?

Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued. The current stock price of MXN557.52 is trading 62% below its estimated GF Value™ of MXN1,468.70.

Key valuation signals for MEX:PRGON:

  • Moat Score: 5
  • GF Value™: MXN1,468.70 vs. price of MXN557.52 (62% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the MEX:PRGON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perrigo Co Business Description

Address The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score

Get the complete analysis for MEX:PRGON

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN557.52
Price
MXN1,468.70
GF Value